BIIB and ESAIY Related Headlines

Go Back

Jul 15, 2026 01:29PM FDA approves Leqembi Iqlik subcutaneous injection for Alzheimer's

Jan 25, 2026 11:52PM FDA accepts Eisai's LEQEMBI IQLIK application for priority review

Nov 26, 2025 06:03AM Eisai completes FDA submission for LEQEMBI subcutaneous starting dose

Sep 1, 2025 12:50AM FDA approves weekly subcutaneous injection for LEQEMBI maintenance dosing

BIIB and ESAIY Related Press Releases

Go Back

BIIB and ESAIY Related SEC Filings

Go Back